Tang Capital Management »

Precigen shares owned by Tang Capital Management

Quarter-by-quarter ownership of Precigen (PGEN) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Precigen

Tip: Access up to 7 years of quarterly data

All positions including Precigen held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precigen by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $41M 12M 3.29
2024-09-30 $474k 500k 0.95

More positions owned by Tang Capital Management

Tarsus Pharmaceuticals (TARS)
Galapagos Nv Spon Adr (GLPG)
Aurinia Pharmaceuticals (AUPH)
Ptc Therapeutics I (PTCT)
Mirum Pharmaceuticals (MIRM)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Immunocore Hldgs Ads (IMCR)
Kalvista Pharmaceuticals (KALV)
Miragen Therapeutics (VRDN)
Compass Therapeutics (CMPX)
Celcuity (CELC)
Merus N V (MRUS)
Spyre Therapeutics Com New (SYRE)
Relay Therapeutics (RLAY)
Lenz Therapeutics (LENZ)

View all positions for Tang Capital Management

Top funds holding Precigen

Patient Capital Management
Tang Capital Management
BlackRock
Vanguard Group
Caption Management
State Street Corporation
Geode Capital Management
Iridian Asset Management
Citadel Advisors
Susquehanna International
Point72 Asset Management
Parkman Healthcare Partners
Driehaus Capital Management
Morgan Stanley
Northern Trust

View all funds holding Precigen